| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.5M | +23.6% |
| R&D Expense | $81.6M | +81.8% |
| SG&A Expense | $49.5M | +52.6% |
| Operating Income | -$116.7M | -77.8% |
| Interest Expense | $3.3M | +12.1% |
| Pre-tax Income | -$114.2M | -66.8% |
| Income Tax | -$1.5M | +8.4% |
| Net Income | -$112.7M | -68.7% |
| EPS (Basic) | -$3.80 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $339.2M | -22.7% |
| Accounts Receivable | $2.0M | +104.5% |
| Current Assets | $369.4M | -19.4% |
| Total Assets | $410.6M | -14.4% |
| Current Liabilities | $53.3M | +47.2% |
| Long-term Debt | $30.3M | +1.5% |
| Total Liabilities | $139.8M | +4.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$86.1M | -482.1% |
| Capital Expenditures | $19.0M | +835.3% |
| Investing Cash Flow | -$19.0M | -835.3% |
| Financing Cash Flow | $6.7M | -97.9% |
| Free Cash Flow | -$105.1M | -524.7% |
| -42.3% |
| EPS (Diluted) | -$3.80 | -42.3% |
| Stockholders' Equity |
| $270.8M |
| -21.8% |